MarketPulse
A

$ANIP

2 articles found
2 positive
0 negative
0 neutral
The Motley FoolThe Motley Fool··Jonathan Ponciano

ANI Pharma Revenue Surges 44% to $883M; Insider Sale Signals Confidence

ANI Pharma posts record $883M revenue (up 44% YoY) with rare disease growth driving performance; insider sells 4,772 shares amid $1B+ 2026 guidance.
ANIPearnings guidancerevenue growth
GlobeNewswire Inc.GlobeNewswire Inc.··Na

ANI Pharmaceuticals to Report 2025 Results, Reaffirms Guidance Expectations

ANI Pharmaceuticals will report 2025 results on February 27, 2026, reaffirming confidence in meeting or exceeding guidance for revenues, EBITDA, and earnings per share.
ANIPfinancial resultsearnings guidance